Case Western Reserve University has received an $8.9 million grant from the National Cancer Institute (NCI) to provide patients with additional access to clinical trials through the National Clinical Trials Network.
The grant aims to speed up the pace of research outcomes through enhanced cooperation and technological advancements.
NCI has selected the Case Comprehensive Cancer Center as one of the Lead Academic Participating Sites. In 2014, the center was selected as one of 30 inaugural Lead Academic Participating Sites, and has since hosted more than 1,000 patients clinical trials under the program.
“This award is just one example of the truly collaborative nature of the Case Comprehensive Cancer Center and the National Clinical Trials Network,” Stanton Gerson, director of the center, said.
“We bring together the best and brightest from our area’s three top hospitals—Cleveland Clinic, the MetroHealth System, and UH Cleveland Medical Center—to share information and work together to design better clinical trials and ultimately improve the lives of the cancer patients that we treat.”
With the latest grant, the center will continue to provide cancer patients with access to the latest and most promising treatment options in collaboration with its three hospital partners—Cleveland Clinic, the MetroHealth System, and University Hospitals (UH) Seidman Cancer Center.
Investigators who are part of the grant said it will further treatment options for future patients as well.
“Through a shared information infrastructure, the center can help speed up the pace of research and offer more trials to patients in Northeast Ohio, including those targeting rare cancers,” Aaron Gerds, grant co-principal investigator, said. “Together with our patients, we are helping shape the future of cancer care.”
2 Medical Schools Receive $13.5M to Address Cancer Health Imbalance